About Testa Center – Testa Center

About Testa Center

Testa Center in brief

In this 2500 m2 (27,000 sq. ft.) upstream / downstream facility, the technology offering from GE includes four start-to-finish bioprocessing laboratories, including bioreactors with working volumes up 500 liters for mammalian cell cultures (50 liters for bacterial) and chromatography equipment from lab to pilot-scale. Dedicated GE Healthcare staff provide hands-on operational support and expertise.

Moreover, the facility also allows educational institutions the chance to offer much-needed training in bioprocessing, thereby ensuring that Sweden maintains a skilled workforce in this key industrial sector.

    What we provide

  • Four industrial-standard bioprocessing laboratories up to pilot-scale (non-GMP) mainly based on single-use technologies
  • Faster, cost-efficient route for verifying processes and technologies
  • Funding and business support smooth the path to commercialization
  • Project owners retain full control of intellectual property and data
  • GE Healthcare staff provide operational support and expertise
  • Advanced training in bioprocessing for educational institutions
  • Owned and operated as a non-profit company by GE Healthcare in Uppsala

Benefits

Verify inovation

Testa Center is a major initiative between the Swedish government and GE to secure the growth of the nation’s life science industry and its manufacturing capabilities in particular. This purpose-built, pilot-scale facility is open to national and international academic research groups, small business enterprises and major industry looking to verify their innovations in the best way possible.

 

Accelerate industrialization

All who use Testa Center’s exceptional facilities gain a more time and cost-effective way to reduce the risks of securing ‘industrial Proof-of-Concept’. Accelerating industrialization in this way is vital for later market introduction and sales. And since many patents have a deadline, shortening time-to-market means higher return-on-investment.

Secure exellence

Being able to verify and define optimized process parameters before transferring production to, for example, a CMO, reduces the risks associated with exposing critical business data to outside parties. You safeguard key company know-how and are less vulnerable to difficult-to-oversee external processes.

Need more information?